Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 5 to 21

Esophagus and stomach movement problems and aspiration risk in children with neurologic impairment

Official title: The Impact of Upper Gastrointestinal Dysmotility on Aspiration-associated Symptoms

Run by Boston Children's Hospital · NCT05455359 · Data updated 2026-11-12

This trial will test prucalopride versus famotidine to see which better reduces coughing, choking, and other aspiration-associated symptoms in tube-fed children ages 5–21 with neurologic impairment.

More Gastro Esophageal Reflux trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages5 Years to 21 Years
SexAll
Enrollment120 (estimated)
SponsorBoston Children's Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedFebruary 13, 2025
Main results expectedMay 31, 2027
Study endsMay 31, 2027
Registry record updatedAugust 3, 2026
Trial IDNCT05455359 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children and young adults (5–21 years) who are tube-fed for >90% of calories, have static neurologic impairment, documented aspiration on video fluoroscopic swallow study, and chronic respiratory symptoms occurring at least three times per week.

Probably not a fit

Patients with progressive neurologic disease, prior intact Nissen fundoplication, current use of antibiotics, or other protocol exclusion criteria would not be eligible and therefore would not benefit from this study's interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a 10-week, randomized crossover Phase 4 trial at Boston Children's Hospital comparing prucalopride (a prokinetic) to famotidine (an acid suppressant) for treating aspiration-associated symptoms. Participants are children and young adults 5–21 years old who receive >90% of calories by enteral tube, have documented aspiration on video fluoroscopic swallow study, static neurologic impairment, and frequent respiratory symptoms. Each participant receives both study medications in sequence with symptom monitoring to compare effects on coughing, choking, need for oral suctioning, and other aspiration-related outcomes. The trial measures short-term symptomatic response rather than long-term disease modification.

Why it matters

Potential benefit: If successful, the trial could identify a medication strategy that reduces coughing, choking, and other aspiration-associated symptoms and potentially lower aspiration-related complications in this high-risk group.

How similar studies have gone: Prior studies of prokinetic or acid-suppressing approaches for aspiration symptoms in children are limited and have shown mixed results, so applying prucalopride versus famotidine in this specific population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. are 5-21 years of age;
2. receive \>90% of their calories by enteral tube (i.e., patients take no food or drink by mouth);
3. are determined to be at high risk for aspiration pneumonia based on evidence of impaired airway protective mechanisms, documented by aspiration on video fluoroscopic swallow study;
4. have static neurologic impairment, defined as functional and/or intellectual impairment that results from a chronic neurologic or related diagnosis (e.g., cerebral palsy) with no prospect of progression for at least one year;
5. have chronic respiratory symptoms, defined as coughing, choking, or need for oral suctioning a minimum of three times per week during the prior four weeks.

   \-

Exclusion Criteria:

1. have progressive neurologic impairment;
2. have a history of prior intact Nissen fundoplication;
3. are currently taking oral or inhaled antibiotics, including prophylactic antibiotics;
4. are currently taking or have taken in the last four weeks acid suppression (H2 antagonist or PPI); or
5. are fed by gastrojejunostomy rather than by gastrostomy. -

Where it's running

  • Boston Children's Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.